Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway.

J M Weiler1, R E Edens, G J Gleich

  • 1Iowa City VA Medical Center, Iowa City.

Journal of Immunology (Baltimore, Md. : 1950)
|July 15, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Memory and Celebration: Dr. James J. Lee.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

Clinical and experimental immunology·2014
Same author

Eosinophil major basic protein activates human cord blood mast cells primed with fibroblast membranes by integrin-β1.

Allergy·2013
Same author

The consequences of not having eosinophils.

Allergy·2013
Same author

Eosinophil peroxidase induces the expression and function of acid-sensing ion channel-3 in allergic rhinitis: in vitro evidence in cultured epithelial cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
Same author

The role of eosinophil major basic protein in angiogenesis.

Allergy·2009
Same journal

Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Crystal structure and immune single-cell atlas provide insights into the functional divergence of type I IFNs in fish.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles

Eosinophil cationic proteins, including eosinophil peroxidase and eosinophil cationic protein, regulate the alternative pathway of complement (C) by inhibiting C3 convertase formation and enhancing decay. Eosinophil-derived neurotoxin showed no such activity.

Area of Science:

  • Immunology
  • Complement System Biology
  • Allergic Inflammation Mechanisms

Background:

  • Eosinophils release cationic proteins that contribute to tissue damage in allergic diseases.
  • The alternative pathway of complement (C) plays a crucial role in innate immunity and inflammation.
  • Understanding how eosinophil granule proteins interact with the complement system is vital for elucidating allergic disease pathogenesis.

Purpose of the Study:

  • To investigate the capacity of eosinophil granule cationic proteins to regulate the alternative pathway of complement (C).
  • To elucidate the mechanisms by which these proteins modulate C activity.
  • To determine the specific roles of eosinophil peroxidase (EPX), eosinophil cationic protein (ECP), major basic protein (MBP), and eosinophil-derived neurotoxin (EDN) in C regulation.

Main Methods:

Related Experiment Videos

  • Assessing the inhibition of alternative pathway C3 convertase formation and lysis using cellular intermediates.
  • Measuring the consumption of fluid-phase Factor B in the presence and absence of C3b and Factor D.
  • Evaluating the decay of preformed alternative pathway C3 convertase.
  • Analyzing the effect of proteins on later complement cascade events.

Main Results:

  • EPX and ECP significantly inhibited C3 convertase formation and lysis, with ECP showing stronger inhibition.
  • MBP exhibited weaker inhibition, while EDN had no effect on alternative pathway activity.
  • EPX and MBP inhibited fluid-phase Factor B consumption, whereas ECP consumed Factor B independently of C3b and Factor D.
  • Both ECP and EPX enhanced the decay of preformed C3 convertase, suggesting action on C3b.
  • No eosinophil proteins affected complement events downstream of C3 convertase formation.

Conclusions:

  • Highly charged eosinophil granule cationic proteins (EPX, ECP, MBP) can regulate alternative pathway C activity.
  • EDN does not appear to regulate the alternative pathway.
  • These proteins likely exert their regulatory effects primarily on C3b.
  • Eosinophil granule proteins may play a significant role in modulating complement-mediated inflammation in vivo.